LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Annals of Oncology

Abbreviated Title: Annals of Oncology

Publisher: Elsevier BV

ISSN (Print): 09237534

Publication date Created: October 2023

Publication date (Print): October 2023

Volume: 34

Page: S1334

Article

DOI: 10.1016/j.annonc.2023.10.096

SO-VID: a3e9d42a-d8fb-4c14-a26a-3c12893020da

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

Cited by 14

See all cited by